Avacta Group Plc AVCTF
Set alert
0.85 USD 0.00 0.00%
At close · Oct 30
0.9598 Day range 0.9598
0.7384 52-week range 1.23
- YTD
- +9.27%
- 1 year
- -19.05%
- Open
- 0.9598
- Prev close
- 0.85
- Mkt cap
- 371.99M
- Vol
- 400
- Avg vol
- 695
- EPS
- -0.12
- P/E
- 0.00
More statistics
- Low
- 0.9598
- High
- 0.9598
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 6 days ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| RSI: Overbought | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
News
- Avacta Group Plc (AVCTF) Q2 2026 Earnings Call Transcript
- Avacta Group Plc (OTCMKTS:AVCTF) Stock Short Interest Report for September
- Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
- Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026
- Avacta Group Plc (AVCTF) Q4 2025 Earnings Call Transcript
- Unaudited Preliminary Results for the Year Ended December 31, 2025
- Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026
- Avacta Group (OTCMKTS:AVCTF) Stock Price Down 5.3% – Here’s What Happened
- Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript
- Avacta Group (OTCMKTS:AVCTF) Trading 1.2% Higher – What’s Next?
Your note
Sign in to keep a note on AVCTF — it syncs with the Stock Master app.